Lichen Sclerosus is a chronic, recurrent condition of the skin and mucous membranes which generally affects the ano-genital region. It is most common in older women and can lead to scarring and degeneration of the skin and mucosa around the genitalia. There is no cure, though treatment with strong topical corticosteroid creams and ointments helps to control the condition.
The Guidelines 2014 - 2017 of European Dermatology Forum (EDF) recognize Dermasilk as an adjuvant tool for the management of Lichen Sclerosus.
Lichen Sclerosus is characterized by changes in the skin of the genital area that becomes thin and faded and develops small white patches which can join up over time. The most common symptom is itch which is often more intense during the night and with the progression of the disease. Localised burning, pain and dryness also occur and sufferers may experience pain during intercourse and difficulty urinating.
The causes of the disease are not completely clear, though it may run in families. It is not a sexually transmitted disease.
Lichen Sclerosus is not thought to be common although figures vary according to different authorities. Some suggest that as many as 1 in 300 women have this condition but it is often undiagnosed or confused with Candida (Thrush) by clinicians. Whilst it is most common in adult women it can also affect pre-pubertal children and adult males too.
DermaSilk Intimo brief demonstrated its efficacy in Vulvar Lichen Sclerosus:
“DermaSilk Briefs in Vulvar Lichen Sclerosus: An Adjuvant Tool .” Journal of Lower Genital Tract Disease 2011